This improved understanding of the mechanistic basis of innate immune sensing, IFN-mediated pathology and inflammatory cell death during SARS-CoV-2 infection informs COVID-19 therapeutic development and provides fundamental molecular details that should be evaluated across interferonopathies. This evidence concerns the gene IFNA1 and COVID-19.